Project Details
Description
Phase I/II Trial of Lenalidomide in Combination with Liposomal Doxorubicin For the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/10 → 12/31/12 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.